Cas 1146977-31-2,1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone

1146977-31-2

Post Buying Request

Basic information

Product Name: 1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone
Synonyms: 1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone
CAS NO:1146977-31-2
Molecular Formula:
Molecular Weight: 359.492
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone(CAS DataBase Reference)
NIST Chemistry Reference: 1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone(1146977-31-2)
EPA Substance Registry System: 1-(3-ethyl-4-methyl-2-{[4-(4-morpholinylmethyl)phenyl]imino}-2,3-hydro-1,3-thiazol-5-yl)ethanone(1146977-31-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1146977-31-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1146977-31-2 Suppliers

Recommended suppliers

1146977-31-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1146977-31-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,6,9,7 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1146977-31:
(9*1)+(8*1)+(7*4)+(6*6)+(5*9)+(4*7)+(3*7)+(2*3)+(1*1)=182
182 % 10 = 2
So 1146977-31-2 is a valid CAS Registry Number.

1146977-31-2Upstream product

1146977-31-2Downstream Products

1146977-31-2Relevant academic research and scientific papers

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

-

Page/Page column 73, (2009/05/28)

The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1146977-31-2